Cystatin C tied to worse heart failure outcomes across ejection fraction spectrum
Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with heart failure (HF) across the ejection fraction (EF) spectrum, according to a study published in Clinical Cardiology.
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] Securing the Untrusted Agentic Development Layer
- [CONFLICT] [World Report] Health on the ballot in Senedd Cymru election
- [CONFLICT] [Perspectives] Amita Aggarwal: understanding autoimmune rheumatic diseases
- [CONFLICT] [Perspectives] Of memory, love, death, and Proust
- [CONFLICT] [Perspectives] Myopic medical harm: a man receives free colon cancer screening in Ghana